SNTI - Senti Biosciences GAAP EPS of -$0.86 revenue of $1.36M
- Senti Biosciences press release ( NASDAQ: SNTI ): Q2 GAAP EPS of -$0.86.
- Revenue of $1.36M (+72.2% Y/Y).
- As of June 30, 2022, Senti Bio held cash and cash equivalents of $139.8M, which the company believes is sufficient to fund operations into 2024.
For further details see:
Senti Biosciences GAAP EPS of -$0.86, revenue of $1.36M